Back to Search
Start Over
Additional file 3 of Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial
- Publisher :
- figshare
-
Abstract
- Additional file 3: Supplementary Table 3. Schematic overview of the study and timeline.
- Subjects :
- 3. Good health
Subjects
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi...........6295584387eea9a82de1ccbc3b59b0b5